$5.04 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 36 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 36.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPR | Buy | SPIRIT AEROSYSTEMS HLDGS INC | $817,244,000 | +13.4% | 16,322,026 | +9.5% | 16.22% | +4.9% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $446,117,000 | +19.4% | 2,848,583 | +0.1% | 8.85% | +10.5% |
| BIDU | Sell | BAIDU INCspon adr rep a | $434,019,000 | +15.1% | 2,295,911 | -16.4% | 8.61% | +6.4% |
| FCEA | Buy | FOREST CITY ENTERPRISES INCcl a | $388,902,000 | +18.6% | 17,733,795 | +8.9% | 7.72% | +9.7% |
| MYGN | Sell | MYRIAD GENETICS INC | $278,776,000 | +9.7% | 6,459,139 | -4.8% | 5.53% | +1.4% |
| ALR | Buy | ALERE INC | $269,758,000 | +15.2% | 6,900,938 | +41.9% | 5.35% | +6.5% |
| MLCO | Buy | MELCO CROWN ENTMT LTDadr | $216,189,000 | +100.7% | 12,868,386 | +64.3% | 4.29% | +85.6% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $207,866,000 | -21.9% | 1,019,600 | -26.6% | 4.12% | -27.8% |
| INSYQ | Buy | INSYS THERAPEUTICS INC NEW | $166,744,000 | +240.9% | 5,824,085 | +238.9% | 3.31% | +215.3% |
| DST | Buy | DST SYS INC DEL | $145,266,000 | +24.6% | 1,273,590 | +14.9% | 2.88% | +15.2% |
| VMW | Buy | VMWARE INC | $144,805,000 | +0.4% | 2,559,749 | +39.9% | 2.87% | -7.1% |
| NFLX | New | NETFLIX INC | $136,091,000 | – | 1,189,813 | +100.0% | 2.70% | – |
| BCO | Buy | BRINKS CO | $135,171,000 | +29.2% | 4,683,689 | +20.9% | 2.68% | +19.5% |
| ITRI | Buy | ITRON INC | $127,867,000 | +108.4% | 3,534,183 | +83.8% | 2.54% | +92.8% |
| HUN | Sell | HUNTSMAN CORP | $120,492,000 | -10.4% | 10,597,325 | -23.6% | 2.39% | -17.1% |
| IWM | Sell | ISHARES TRput | $116,764,000 | -57.0% | 1,036,800 | -58.3% | 2.32% | -60.3% |
| CABO | Sell | CABLE ONE INC | $102,676,000 | -19.8% | 236,767 | -22.5% | 2.04% | -25.9% |
| FICO | New | FAIR ISAAC CORP | $91,722,000 | – | 973,899 | +100.0% | 1.82% | – |
| MLNX | Sell | MELLANOX TECHNOLOGIES LTD | $91,301,000 | -22.1% | 2,166,609 | -30.2% | 1.81% | -28.0% |
| EXPR | Buy | EXPRESS INC | $88,293,000 | +9.5% | 5,109,550 | +13.3% | 1.75% | +1.3% |
| ACOR | Buy | ACORDA THERAPEUTICS INC | $83,567,000 | +455.7% | 1,953,423 | +244.3% | 1.66% | +413.3% |
| IBKR | New | INTERACTIVE BROKERS GROUP IN | $82,000,000 | – | 1,880,740 | +100.0% | 1.63% | – |
| BNCL | Sell | BENEFICIAL BANCORP INC | $81,719,000 | -19.7% | 6,135,044 | -20.0% | 1.62% | -25.7% |
| AEGR | AEGERION PHARMACEUTICALS INC | $57,606,000 | -25.7% | 5,703,587 | 0.0% | 1.14% | -31.3% | |
| MLCO | MELCO CROWN ENTMT LTDcall | $52,092,000 | +22.1% | 3,100,700 | 0.0% | 1.03% | +13.0% | |
| Buy | NEURODERM LTD | $46,871,000 | +68.8% | 2,749,038 | +104.6% | 0.93% | +56.0% | |
| AAAP | New | ADVANCED ACCELERATOR APPLICsponsored ads | $28,071,000 | – | 897,687 | +100.0% | 0.56% | – |
| BKD | Sell | BROOKDALE SR LIVING INC | $27,102,000 | -79.8% | 1,468,133 | -74.9% | 0.54% | -81.3% |
| GATX | Buy | GATX CORP | $17,485,000 | +13.2% | 410,935 | +17.4% | 0.35% | +4.5% |
| FLDM | Buy | FLUIDIGM CORP DEL | $16,303,000 | +53.7% | 1,508,120 | +15.3% | 0.32% | +41.7% |
| RTRX | New | RETROPHIN INC | $7,121,000 | – | 369,135 | +100.0% | 0.14% | – |
| LNTH | Buy | LANTHEUS HLDGS INC | $7,071,000 | -15.2% | 2,091,926 | +7.9% | 0.14% | -21.8% |
| FOSL | FOSSIL GROUP INC | $2,628,000 | -34.6% | 71,890 | 0.0% | 0.05% | -39.5% | |
| AROPQ | Sell | AEROPOSTALE | $2,003,000 | -67.4% | 7,154,015 | -27.8% | 0.04% | -69.7% |
| QLTI | Sell | QLT INC | $1,687,000 | -81.0% | 634,087 | -81.0% | 0.03% | -82.6% |
| PSEC | Sell | PROSPECT CAPITAL CORPORATION | $698,000 | -95.7% | 100,000 | -95.6% | 0.01% | -95.9% |
| AMSC | Exit | AMERICAN SUPERCONDUCTOR CORP | $0 | – | -19,610 | -100.0% | -0.00% | – |
| Exit | THERAVANCE INCnote 2.125% 1/1 | $0 | – | -1,500,000 | -100.0% | -0.02% | – | |
| KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -702,795 | -100.0% | -0.05% | – |
| SLCA | Exit | U S SILICA HLDGS INC | $0 | – | -795,341 | -100.0% | -0.24% | – |
| SGNT | Exit | SAGENT PHARMACEUTICALS INC | $0 | – | -1,098,590 | -100.0% | -0.36% | – |
| GNRC | Exit | GENERAC HLDGS INC | $0 | – | -1,671,507 | -100.0% | -1.08% | – |
| ARPI | Exit | AMERICAN RESIDENTIAL PPTYS I | $0 | – | -3,150,754 | -100.0% | -1.17% | – |
| SALE | Exit | RETAILMENOT INC | $0 | – | -6,923,057 | -100.0% | -1.22% | – |
| XLE | Exit | SELECT SECTOR SPDR TRsbi int-energy | $0 | – | -1,053,699 | -100.0% | -1.38% | – |
| ZSPH | Exit | ZS PHARMA INC | $0 | – | -1,002,444 | -100.0% | -1.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
| ISHARES TR | 28 | Q3 2023 | 10.9% |
| MANNKIND CORP | 24 | Q3 2023 | 0.5% |
| BAIDU INC | 21 | Q2 2018 | 8.6% |
| ITRON INC | 21 | Q3 2020 | 12.1% |
| RETROPHIN INC | 20 | Q3 2020 | 4.5% |
| HARMONIC INC | 19 | Q3 2023 | 10.5% |
| JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
| ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
| Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
| Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
| Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
| ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
| ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
| ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
| Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
| GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2024-04-26 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-01-22 |
| 13F-HR/A | 2023-11-14 |
| 13F-HR | 2023-11-14 |
| SC 13D | 2023-09-21 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.